ReviewPalliative care2017
Burden and Management of Multidrug-Resistant Organisms in Palliative Care.
Review in Palliative care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 31 citations in OpenAlex.
- Comparison of Broad-Spectrum Antibiotic Use According to Hospice Utilization Among Patients with Cancer at the End of Life in South Korea: A Nationwide Analysis.Journal of hospice and palliative care · 2026Article
- Surveillance of Multidrug-Resistant Organisms and Trends in Antimicrobial Susceptibility in Chronically Hospitalized Pediatric Patients.Infection & chemotherapy · 2025Article
- End-of-Life Infections and the Dilemma of Emerging Antimicrobial Resistance: A Scoping Review.Infection & chemotherapy · 2025Review
- Precaution or barrier? Reconsidering contact and isolation measures in palliative care: a systematic scoping review.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
- Analysis of microbiological tests in patients withholding or withdrawing life-sustaining treatment at the end stage of life in 2 Korean hospitals.Infection control and hospital epidemiology · 2024Article
- Spatiotemporal prediction of vancomycin-resistant Enterococcus colonisation.BMC infectious diseases · 2022Article
- Clinical Significance of Manuka and Medical-Grade Honey for Antibiotic-Resistant Infections: A Systematic Review.Antibiotics (Basel, Switzerland) · 2020Review
- Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study.Epidemiology and infection · 2020Article
- Palliative care and infection management at end of life in nursing homes: A descriptive survey.Palliative medicine · 2020Article
- Multidrug-resistant bacteria in a paediatric palliative care inpatient unit: results of a one year surveillance.GMS hygiene and infection control · 2020Article
- Increased Length of Stay Associated With Antibiotic Use in Older Adults With Advanced Cancer Transitioned to Comfort Measures.The American journal of hospice & palliative care · 2020Article
- Implementation of Antimicrobial Stewardship Programs in End-of-Life Care.Infection & chemotherapy · 2019Review
- Antimicrobial therapy for asymptomatic bacteriuria or candiduria in advanced cancer patients transitioning to comfort measures.Infection control and hospital epidemiology · 2019Article
- Design and analysis of longitudinal trials of antimicrobial use at the end of life: to give or not to give?Therapeutic advances in drug safety · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Palliative care includes comprehensive strategies to optimize quality of life for patients and families confronting terminal illness. Infections are a common complication in terminal illness, and infections due to multidrug-resistant organisms (MDROs) are particularly challenging to manage in palliative care. Limited data suggest that palliative care patients often harbor MDRO. When MDROs are present, distinguishing colonization from infection is challenging due to cognitive impairment or metastatic disease limiting symptom assessment and the lack of common signs of infection. Multidrug-resistant organisms also add psychological burden through infection prevention measures including patient isolation and contact precautions which conflict with the goals of palliation. Moreover, if antimicrobial therapy is indicated per goals of care discussions, available treatment options are often limited, invasive, expensive, or associated with adverse effects that burden patients and families. These issues raise important ethical considerations for managing and containing MDROs in the palliative care setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.